PRPH 0.78 (-45.45%)
US74345W1080Drug ManufacturersDrug Manufacturers - Specialty & Generic

ProPhase Labs (PRPH) Competitor Comparison

We are evaluating the key criteria listed to compare ProPhase Labs (PRPH) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 3 years - PRPH ranking 14 / 54

These are the competitors of ProPhase Labs in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 3 years
1. Phibro Animal Health PAHC
28.93
2. Kamada KMDA
28.2
3. Supernus Pharmaceuticals SUPN
15.68
4. Kolinpharma KIP.MI
11.59
5. Zoetis ZTS
9.93
6. Alimera Sciences ALIM
8.97
7. Vifor Pharma G2AB.F
6.24
8. Alvotech ALVO
6.19
9. ANI Pharmaceuticals ANIP
5.08
10. Perrigo PRGO
5.04
11. PetIQ PETQ
5.03
12. Taro Pharmaceutical Industries TARO
3.87
13. Cumberland Pharmaceuticals CPIX
3.85
14. ProPhase Labs PRPH
3.8
15. Ironwood Pharmaceuticals IRWD
3.69
16. Avadel Pharmaceuticals AVDL
3.38
17. Regencell Bioscience Holdings RGC
3.23
18. Pacira BioSciences PCRX
3.1
19. Collegium Pharmaceutical COLL
3.01
20. Catalent CTLT
3
21. Zynerba Pharmaceuticals ZYNE
3
22. Linc LNC
2.97
23. Journey Medical DERM
2.78
24. Elanco Animal Health ELAN
2.71
25. Embecta EMBC
2.61
26. OptiNose OPTN
2.55
27. Societal CDMO SCTL
2.41
28. Green Thumb Industries R9U2.F
2.4
29. Emergent BioSolutions EBS
2.3
30. SCYNEXIS SCYX
2.28
31. Evolus EOLS
2.23
32. Bausch Health Companies BHC
2.23
33. Cronos Group CRON
2.23
34. Procaps Group PROC
2.19
35. Curaleaf Holdings CURLF
2.17
36. Organogenesis Holdings ORGO
2.03
37. Relmada Therapeutics RLMD
1.99
38. Amphastar Pharmaceuticals AMPH
1.99
39. Eagle Pharmaceuticals EGRX
1.94
40. Teva Pharmaceutical Industries TEVA
1.86
41. Jupiter Wellness JUPW
1.84
42. Theratechnologies THTX
1.79
43. Ascend Wellness Holdings AAWH
1.76
44. Flora Growth FLGC
1.74
45. Universe Pharmaceuticals UPC
1.74
46. Solid Biosciences SLDB
1.69
47. Biofrontera BFRI
1.68
48. Alpha Teknova TKNO
1.64
49. Neoleukin Therapeutics NLTX
1.57
50. Tilray Brands TLRY
1.57
51. Amneal Pharmaceuticals AMRX
1.48
52. Clever Leaves Holdings CLVR
1.47
53. Ayr Wellness 3KJB.F
1.41
54. Harrow Health HROW
0.38

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.